Skip to main content
. 2023 Mar 31;14:1142374. doi: 10.3389/fphar.2023.1142374

graphic file with name FPHAR_fphar-2023-1142374_wc_abs.jpg

The PEG-PLGA nanoparticles effectively delivered R848 and CD47 siRNA into tumor cells, resulting in simultaneous activation of DCs and downregulation of CD47 expression on tumor cells, thereby enhancing antitumor immune responses by T cells.